FMP
Feb 4, 2025 2:04 AM - Gordon Thompson
Image credit: Google Images
AXIS Capital Holdings Limited (NYSE:AXS), a global provider of specialty insurance and reinsurance solutions, competes with other major players in the insurance industry. The company aims to maintain its market position through strategic initiatives and financial performance.
On February 3, 2025, Charles A. Davis, a director of AXS, sold 2,234,636 shares of the company's common stock at $89.50 per share. This transaction was documented on Form 4. Despite this significant sale, Davis still retains 4,543,170 shares of AXS, indicating his continued investment in the company.
Recently, AXS held its Q4 2024 earnings conference call on January 30, 2025. Key figures such as Vince Tizzio, President and CEO, and Pete Vogt, CFO, participated in the call. Analysts from major financial institutions like TD Securities and Bank of America attended, highlighting the importance of the event in providing insights into AXS's financial health and future plans.
The current stock price of AXS is $90.16, showing a slight decrease of $0.86, or -0.94%. The stock has experienced fluctuations today, with a low of $88.99 and a high of $90.62. Over the past year, AXS has seen a high of $94.89 and a low of $56.93, reflecting its volatility in the market.
AXS has a market capitalization of approximately $7.54 billion, indicating its size and presence in the industry. The trading volume stands at 659,880 shares, suggesting active investor interest. These metrics are crucial for investors assessing the company's market performance and potential investment opportunities.
Feb 3, 2025 9:00 PM - Andrew Wynn
Healthpeak Properties, Inc., trading as DOC on the NYSE, is a real estate investment trust (REIT) that focuses on owning and developing healthcare properties. The company operates in a competitive market, with peers like Ventas and Welltower. Healthpeak's portfolio includes medical offices, life sci...
Feb 3, 2025 10:00 PM - Andrew Wynn
Cabot Corporation (NYSE: CBT) is a key player in the chemical industry, specializing in the production of specialty chemicals and performance materials. The company operates in the Zacks Chemical - Diversified industry, competing with other major chemical manufacturers. Cabot's recent financial perf...